
cancer patients and caregivers
Clinical ProjectsCanceRx LLC
CanceRx LLC
Projects
At CanceRx, we have several projects under review. Those nearing completion of early stage negotiations include:
We are making strategic selections for novel therapies as we scale up our clinical development operations.”
Cody Gibbons, COO, CanceRx
Novel Drug Delivery System, Polymeric Nanoparticles
Pancreatic Cancer
A Phase I Clinical Trial to Evaluate Tolerability and Safety of XXXX-PNP-PEG Infusion for Advanced Pancreatic Carcinoma.
A Phase II Clinical Trial to Evaluate Tolerability and Safety of XXXX -PNP-PEG in Subjects with Early-Stage Pancreatic Cancer.
A Phase II Clinical Trial to Evaluate Tolerability and Safety of XXXX -PNP-PEG in Subjects with Early-Stage Pancreatic Cancer.
Leukemia
A Phase I Clinical Trial to Evaluate Safety and Tolerability of XXXX-PNP-PEG infusion in Subjects with Acute Myelogenous Leukemia.
A Phase I/II Clinical Trial of XXXX-PNP-PEG in the Treatment of Chronic Lymphocytic Leukemia and Small Lymphocytic Leukemia.
A Phase I/II Clinical Trial of XXXX-PNP-PEG in the Treatment of Chronic Lymphocytic Leukemia and Small Lymphocytic Leukemia.
Lymphoma
A Phase I Clinical Trial to Evaluate Safety and Tolerability of XXXX-PNP-PEG infusion in Subjects with Advanced Non-Hodgkin’s Lymphoma.
A Phase I /II Clinical Trial to Evaluate Safety and Tolerability of XXXX-PNP-PEG infusion in Subjects with T-Cell Lymphoma.
A Phase I/ II Clinical Trial of XXXX-PNP-PEG in the Treatment of Relapsed Refractory Follicular Lymphoma.
A Phase I /II Clinical Trial to Evaluate Safety and Tolerability of XXXX-PNP-PEG infusion in Subjects with T-Cell Lymphoma.
A Phase I/ II Clinical Trial of XXXX-PNP-PEG in the Treatment of Relapsed Refractory Follicular Lymphoma.
General Malignancy
A Phase I/ II Clinical Trial of XXXX-PNP-PEG in the Treatment of Advanced Malignant Tumors.
A Phase I/ II Clinical Trial of XXXX-PNP-PEG in the Treatment of Non-Small Cell Lung Cancer.
A Phase I/ II Clinical Trial of XXXX-PNP-PEG in the Treatment of Colorectal Cancer.
A Phase I/ II Clinical Trial of XXXX-PNP-PEG in the Treatment of Non-Small Cell Lung Cancer.
A Phase I/ II Clinical Trial of XXXX-PNP-PEG in the Treatment of Colorectal Cancer.
Novel Drug Delivery System, Polymeric Viral Vectors
Ovarian Cancer
A Phase I Clinical Trial to Evaluate Tolerability and Safety of XXXX-PVV Infusion in Subjects with Advanced Ovarian Cancer.
A Phase I/II A Clinical Trial to Evaluate Safety, Tolerability and Efficacy of XXXX -PVV Infusion in Subjects with Early-Stage Ovarian Cancer.
A Phase I/II A Clinical Trial to Evaluate Safety, Tolerability and Efficacy of XXXX -PVV Infusion in Subjects with Early-Stage Ovarian Cancer.
Multiple Myeloma
A Phase I Clinical Trial to Evaluate Safety and Tolerability of XXXX-PVV infusion in Subjects with Advanced Multiple Myeloma.
Getting In Touch
We encourage you to reach out with questions about CanceRx.
By submitting this form, you are consenting to receive marketing emails from: CanceRx. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact